Please wait a minute...
European Journal of Gynaecological Oncology  2019, Vol. 40 Issue (6): 1067-1069    DOI: 10.12892/ejgo4775.2019
Case Report Previous articles | Next articles
Isolated late recurrence of epithelial ovarian cancer in cervical lymph nodes
A. Antar1, *(), H. AlJawad2, A. AlMuslim3, N. El-Majzoub4
1Department of Internal Medicine, Division of Hematology-Oncology, Almoosa Specialist Hospital, Al-Ahsa, Saudi Arabia
2Department of Pathology and Laboratory Medicine, Almoosa Specialist Hospital, Al-Ahsa, Saudi Arabia
3Department of Diagnostic Radiology, Almoosa Specialist Hospital, Al-Ahsa, Saudi Arabia
4Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Download:  PDF(659KB)  ( 265 ) Full text   ( 5 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Ovarian cancer is the most common cause of gynecologic cancer death worldwide. Ninety-five percent of ovarian malignancies derive from epithelial cells. Dissemination of ovarian cancer is usually locoregional and occurs by invasion of adjacent viscera. Recurrence in the supradiaphragmatic lymph nodes is rare and only reported in a few cases in the literature. The authors describe the finding of a late metastasis in the cervical lymph nodes in a 56-year-old patient with ovarian serous cell carcinoma.

Key words:  Chemotherapy      Computerized tomography      Neck metastasis      Ovarian cancer     
Published:  10 December 2019     
*Corresponding Author(s):  A. ANTAR     E-mail:  a.antar@almoosahospital.com.sa

Cite this article: 

A. Antar, H. AlJawad, A. AlMuslim, N. El-Majzoub. Isolated late recurrence of epithelial ovarian cancer in cervical lymph nodes. European Journal of Gynaecological Oncology, 2019, 40(6): 1067-1069.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4775.2019     OR     https://ejgo.imrpress.com/EN/Y2019/V40/I6/1067

[1] Yu Hui Lim, Sheow Lei Lim, Linda Xiao Hui Lin, Lay Tin Soh, Hoon Seng Khoo Tan, Richard Ming Chert Yeo, Timothy Yong Kuei Lim. Sequential Chemoradiation versus Radiation for the Adjuvant Treatment of Stage III Endometrioid Adenocarcinoma of the Uterus[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 705-712.
[2] Buse Güler, Merve Çamlıbel, Samiye Mete. What Do Relatives of Turkish Women with Ovarian Cancer Share on Websites? : A Qualitative Research[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 732-738.
[3] Yanan Li, Dongge Wang, Xiaodong Li, Wangchao Zhang, Xianghua Huang, Yibin Liu. Appendix invasion of squamous cell carcinoma arising from ovarian mature cystic teratoma and resistant to combination chemotherapy with docetaxel and oxaliplatin: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 841-844.
[4] Yudi Mulyana Hidayat, Gatot Nyarumenteng Adhipurnawan Winarno, Maringan Diapari Lumban Tobing, Arieff Kustiandi, Kemala Isnainiasih Mantilidewi, Sofie Rifayani Krisnadi. The Role of Akt2 and CA-125 Serum Levels as Predictors for Successful Cytoreduction in Epithelial Ovarian Cancer Surgery[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 739-744.
[5] Lingyun Zhai, Lixin Zeng, Hongru Jiang, Wei Li. Effects of a cyclooxygenase-1-selective inhibitor in combination with taxol or cisplatin on cyclin D1, apoptosis, and vascular endothelial growth factor in a xenograft model of ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 779-784.
[6] Yan qin Zhang, Di Wu, Meng qi Deng, Xiang yu Chang, Jin wei Miao, Yu mei Wu. Individual management of cervical cancer during pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 833-837.
[7] Qinglian Ma, Wenjie Yan, Jing Yang, Haiyan Wang, Weixiang Wang, Minghui Dong. Functional interpretation of ovarian cancer in correlation with ISGF3 expression pattern[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 769-773.
[8] Joseph J. Noh, Sir-Yeon Hong, Byeong-gie Kim. Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 495-499.
[9] Silvia Ortega, José Angel Mínguez, José Manuel Aramendía, Marta Santisteban, Fernando Martinez-Regueira, Pablo Martí-Cruchaga, Juan Luis Alcázar, Matías Jurado. The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 523-530.
[10] Jae Hong Sang, Soo-Ho Chung. Is it enough in ovarian cancer staging surgery to laparoscopic surgery? Comparison of surgical methods[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 541-544.
[11] Krittiya Somaketarin, Charuwan Tantipalakorn, Kittipat Charoenkwan, Prapaporn Suprasert, Jatupol Srisomboon. Survival outcomes of sex cord-stromal tumors of the ovary[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 563-568.
[12] Sigit Purbadi, Gregorius Tanamas, Lisa Novianti. Advanced stage ovarian cancer survival in Jakarta[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 587-590.
[13] Gen-Hai Zhu, Kang Wang, Lan Hong, Xin-Hui Fu, Fu-Jin Liu, Hai-Yan Huang. Safety and efficacy of fertility-sparing surgery for an orthotopic xenograft model of epithelial ovarian cancer in nude mice[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 609-616.
[14] Xifang Lv, Amanguli, Ping Yang. The role of sodium hydrosulfide in the proliferation and apoptosis of exogenous SB203580 pre-treated human ovarian cancer cells[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 622-628.
[15] F. Oyama, Y. Asano, H. Shimoda, K. Horie, J. Watanabe, Y. Yokoayama. Morphological analysis of peritoneal dissemination of ovarian cancer based on levels of carbonyl reductase 1 expression[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 352-360.
No Suggested Reading articles found!